Uniqure Is A Biotechnology Company Based In Amsterdamnetherlandsfounded In 1998The Company Focuses On Developing And Marketing Gene Therapy Productsparticularly Those Utilizing Adeno Associated Virusaavtechnologyuniqure Aims To Leverage Genomic Medicine To Create Innovative Treatments For Severe Genetic Diseases And Other Serious Conditions The Company Is Engaged In The Development And Commercialization Of Gene Therapiescollaborating With Academic Institutions For Drug Discovery And Preclinical Researchuniqure Has Established Partnerships With Pharmaceutical Companies To Enhance Its Research Capabilities And Broaden Patient Access To Its Therapiesits Product Pipeline Includes Amt 060 For Hemophilia Bamt 130 For Huntington S Diseaseand Amt 150 For Spinocerebellar Ataxia Type 3Among Othersnotablyglyberawhich Received The First Gene Therapy Approval In Europe In 2012Was A Significant Milestone For The Company
No conferences found for this company.
| Company Name | Amsterdam Molecular Therapeutics |
| Country |
Netherlands
|
| Address | N/A |
| Telephone | N/A |
| N/A |
